ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

Longmire Reappointed To Cancer Panel

April 8, 1988

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008

NCI-Approved Clinical Trials

December 30, 2005

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986

Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says

March 20, 1998